PY PERMANENT PACING LEAD
Report
- Report Number
- 1035166-2023-00097
- Event Type
- Injury
- Date Received
- September 6, 2023
- Date of Event
- August 3, 2023
- Report Date
- September 6, 2023
- Manufacturer
- OSCOR.INC
- Product Code
- DTB
- PMA / PMN Number
- K862330
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MN, US
- Reporter Occupation
- 003
Narratives
THE LEAD WAS NOT RETURNED FOR ANALYSIS AS LEAD WAS CAPPED AND SURGICALLY ABANDONED DUE TO IT PRESENTING A DEGRADING PERFORMANCE AFTER 25 YEARS IN SERVICE. A NEW DEVICE WAS IMPLANTED. NO ADDITIONAL PATIENT EFFECTS WERE REPORTED. THE LEAD WAS IN USE FOR TREATMENT AND THERE WAS NO PRODUCT MALFUNCTION REPORTED. BASED UPON THE IMPLANT DATE OF THIS LEAD (B)(6) 1998, QA IS UNABLE TO REVIEW THE DEVICE HISTORY RECORDS FOR THIS LEAD MODEL AS IT IS BEYOND OSCOR'S RECORD RETENTION PERIOD, HOWEVER, INSPECTION PROCEDURES REQUIRE ANY OSCOR PRODUCT TO PASS ALL IN-PROCESS AND QA FINAL INSPECTION BEFORE SHIPPING TO THE CUSTOMER. THEREFORE, THIS COMPLAINT IS UNCONFIRMED - NO PROBLEM DETECTED. THIS DEVICE IS NO LONGER MANUFACTURED BY MANUFACTURE. NO CORRECTIONS WILL BE TAKEN AT THIS TIME AS NO ALLEGATION WAS MADE AGAINST THE LEAD. OSCOR INC. IS SUBMITTING THE ABOVE REPORT TO COMPLY WITH 21 CFR PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THE REPORT IS BASED UPON INFORMATION OBTAINED BY OSCOR INC. WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY FDA. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION THAT THE DEVICE, OSCOR INC., OR ITS EMPLOYEES, CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THIS REPORT. NOR DOES THIS REPORT REFLECT A CONCLUSION BY FDA, OSCOR INC., OR ITS EMPLOYEES, THAT THE REPORT CONSTITUTES AN ADMISSION THAT THE DEVICE, OSCOR INC., OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THIS REPORT.
IT WAS REPORTED THAT THIS RIGHT ATRIAL (RA) LEAD WAS CAPPED AND SURGICALLY ABANDONED DUE TO IT PRESENTING A DEGRADING PERFORMANCE AFTER 25 YEARS IN SERVICE. A NEW DEVICE WAS IMPLANTED. NO ADDITIONAL PATIENT EFFECTS WERE REPORTED. NO ADDITIONAL INFORMATION IS AVAILABLE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 987999 | PY PERMANENT PACING LEAD | PERMANENT PACEMAKER ELECTRODE | DTB | OSCOR.INC | PY 44 PSBV |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 80 YR | Female | Required Intervention |